COCCETTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 9.844
EU - Europa 5.974
AS - Asia 5.642
SA - Sud America 862
AF - Africa 158
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.502
Nazione #
US - Stati Uniti d'America 9.336
IT - Italia 2.015
SG - Singapore 1.797
CN - Cina 1.299
DE - Germania 1.130
VN - Vietnam 819
BR - Brasile 689
HK - Hong Kong 607
RU - Federazione Russa 594
SE - Svezia 506
CA - Canada 429
IE - Irlanda 320
GB - Regno Unito 261
FR - Francia 240
UA - Ucraina 234
IN - India 204
BD - Bangladesh 180
PL - Polonia 171
TR - Turchia 138
KR - Corea 126
FI - Finlandia 115
ID - Indonesia 86
ES - Italia 72
IQ - Iraq 70
NL - Olanda 70
AT - Austria 69
AR - Argentina 56
MX - Messico 52
DK - Danimarca 50
ZA - Sudafrica 46
JP - Giappone 45
PK - Pakistan 44
PH - Filippine 36
BE - Belgio 35
SA - Arabia Saudita 31
EC - Ecuador 28
CH - Svizzera 21
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
VE - Venezuela 20
MA - Marocco 19
CO - Colombia 17
ET - Etiopia 17
CL - Cile 16
RO - Romania 16
TH - Thailandia 16
EG - Egitto 15
MY - Malesia 14
IR - Iran 13
PY - Paraguay 13
BO - Bolivia 11
CZ - Repubblica Ceca 11
JO - Giordania 11
DZ - Algeria 9
KE - Kenya 9
NP - Nepal 9
PT - Portogallo 9
JM - Giamaica 8
LT - Lituania 8
NZ - Nuova Zelanda 8
SN - Senegal 8
CY - Cipro 7
EU - Europa 7
MU - Mauritius 7
NG - Nigeria 7
TN - Tunisia 7
IL - Israele 6
LB - Libano 6
PS - Palestinian Territory 6
AU - Australia 5
BG - Bulgaria 5
CR - Costa Rica 5
KZ - Kazakistan 5
HN - Honduras 4
OM - Oman 4
PE - Perù 4
TW - Taiwan 4
UY - Uruguay 4
AO - Angola 3
AZ - Azerbaigian 3
BS - Bahamas 3
GR - Grecia 3
MN - Mongolia 3
NO - Norvegia 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
GA - Gabon 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
Totale 22.479
Città #
Ann Arbor 1.376
Singapore 1.102
Ashburn 1.007
Milan 778
Frankfurt am Main 734
Hong Kong 588
San Jose 551
Woodbridge 521
Fairfield 499
Chandler 419
Wilmington 394
Houston 393
Dublin 307
Toronto 270
Ho Chi Minh City 245
New York 232
Jacksonville 227
Los Angeles 221
Seattle 204
Santa Clara 191
Hefei 188
Cambridge 183
Hanoi 172
Beijing 166
Dallas 155
Dearborn 148
Kraków 137
Chicago 131
Seoul 111
Princeton 103
Shanghai 93
Dong Ket 92
Nanjing 92
The Dalles 88
Rome 86
Boardman 81
Buffalo 81
Lauterbourg 72
Council Bluffs 67
Jakarta 64
Munich 64
Helsinki 60
São Paulo 57
Altamura 55
Moscow 54
Lawrence 50
Vienna 48
Lachine 39
Oakland 37
Columbus 36
Brussels 35
Guangzhou 35
San Diego 33
Fremont 32
London 32
Baghdad 30
Hyderabad 30
Da Nang 29
Tokyo 29
Orem 27
Stuttgart 27
Warsaw 27
Montreal 26
Nuremberg 26
Phoenix 26
Naples 25
Washington 25
Atlanta 23
Bari 23
Mexico City 23
Ottawa 23
Amsterdam 22
Haiphong 22
Nanchang 22
Poplar 22
Tianjin 22
Brooklyn 21
Chennai 21
Fisciano 21
Heidelberg 21
Kent 21
Monza 21
Mumbai 20
Rio de Janeiro 20
Shenyang 20
Tashkent 19
Andover 18
Johannesburg 18
Montréal 18
Desio 17
Hebei 17
Istanbul 17
Jeddah 17
Jinan 17
Boston 16
Changsha 16
Denver 16
Turin 16
Xi'an 16
Desenzano del Garda 15
Totale 14.204
Nome #
Post-translational modifications on yeast carbon metabolism: Regulatory mechanisms beyond transcriptional control 782
Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease 680
Targeting GRP receptor: design, synthesis and preliminary biological characterization of new non-peptide antagonists of bombesin 476
Respiratory metabolism and calorie restriction relieve persistent endoplasmic reticulum stress induced by calcium shortage in yeast 474
Protective effect of Vigna unguiculata extract against aging and neurodegeneration 460
1,4-Diaril-2-Azetidinoni ad attività antitumorale. 444
Snf1/AMPK is involved in the mitotic spindle alignment in Saccharomyces cerevisiae 427
The regulatory role of key metabolites in the control of cell signaling 418
Potential role of neglected and underutilized plant species in improving women's empowerment and nutrition in areas of sub-Saharan Africa 407
Methionine Supplementation Affects Metabolism and Reduces Tumor Aggressiveness in Liver Cancer Cells 402
Anti-aging effects of plant extracts on eukaryotic models of Parkinson’s disease 391
Bioactive compounds in legumes: Implications for sustainable nutrition and health in the elderly population 385
Methionine supplementation stimulates mitochondrial respiration 379
Enhanced amino acid utilization sustains growth of cells lacking Snf1/AMPK 374
NMR analysis of budding yeast metabolomics: A rapid method for sample preparation 372
AMPK Phosphorylation Is Controlled by Glucose Transport Rate in a PKA-Independent Manner 372
CK2 activity is modulated by growth rate in Saccharomyces cerevisiae 361
Nutritional modulation of CK2 in Saccharomyces cerevisiae: regulating the activity of a constitutive enzyme 357
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 354
An acidic loop and cognate phosphorylation sites define a molecular switch that modulates ubiquitin charging activity in cdc34-like enzymes 349
The overexpression of the 3' terminal region of the CDC25 gene of Saccharomyces cerevisiae causes growth inhibition and alteration of purine nucleotides pools 348
Snf1 phosphorylates adenylate cyclase and negatively regulates protein kinase A-dependent transcription in Saccharomyces cerevisiae 318
Conventional and emerging roles of the energy sensor snf1/AMPK in saccharomyces cerevisiae 317
Dual action antifungal small molecule modulates multidrug efflux and TOR signaling 315
Targeting protein aggregation using a cocoa-bean shell extract to reduce α-synuclein toxicity in models of Parkinson's disease 310
CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake 308
Synthesis and biological evaluation of new 3-amino-2-azetidinone derivatives as anti-colorectal cancer agents 307
Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling 306
Cell growth and cell cycle in Saccharomyces cerevisiae: Basic regulatory design and protein-protein interaction network 305
Snf1/AMPK promotes SBF and MBF-dependent transcription in budding yeast 305
Exploring Influence of Production Area and Harvest Time on Specialized Metabolite Content of Glycyrrhiza glabra Leaves and Evaluation of Antioxidant and Anti-Aging Properties 303
Industrial Production of Proteins with Pichia pastoris-Komagataella phaffii 303
3-Nitrocoumarin is an efficient inhibitor of budding yeast phospholipase-C 303
Glucose signaling-mediated coordination of cell growth and cell cycle in Saccharomyces Cerevisiae 298
Synthesis and biological evaluation of 1,4-diaryl-2-azetidinones as specific anticancer agents: activation of adenosine monophosphate-activated protein kinase and induction of apoptosis 293
Insulin and serine metabolism as sex-specific hallmarks of Alzheimer's disease in the human hippocampus 285
Loop 7 of E2 enzymes: an ancestral conserved functional motif involved in the E2-mediated steps of the ubiquitination cascade 285
Phosphorylation of Cdc28 and regulation of cell size by the protein kinase CKII in Saccharomyces cerevisiae 284
Protein Kinase CK2 Holoenzyme Promotes Start-Specific Transcription in Saccharomyces cerevisiae 284
Anti-Aging and Neuroprotective Properties of Grifola frondosa and Hericium erinaceus Extracts 271
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 271
The overexpression of the CDC25 gene of Saccharomyces cerevisiae causes a derepression of GAL system and an increase of GAL4 transcription 268
Sic1 is phosphorylated by CK2 on Ser201 in budding yeast cells 267
2013.Use of 1,4-diaryl-2-azetidinone compound as antitumor agent for treating lung cancer, large-cell lung cancer, renal carcinoma, prostate cancer, testicular cancer, ovarian cancer, bladder cancer and melanoma Patent Number(s): WO2013017548-A1 265
The minimal active domain of the mouse Ras exchange factor CDC25Mm 264
Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae 262
The yeast cyclin-dependent kinase inhibitor Sic1 shares a functionally and structurally homologous domain with mammalian p27Kip1 259
In CK2 inactivated cells the cyclin dependent kinase inhibitor Sic1 is involved in cell-cycle arrest bifore the onset of S phase 259
The PLC1 encoded phospholipase C in the yeast Saccharomyces cerevisiae is essential for glucose-induced phosphatidylinositol turnover and activation of plasma membrane H+-ATPase 258
Analysis of the secondary structure of the catalytic domain of mouse Ras exchange factor CDC25(Mm) 257
Systems biology of the cell cycle of Saccharomyces cerevisiae: From network mining to system-level properties 254
Snf1/AMPK promotes S-phase entrance by controlling CLB5 transcription in budding yeast 250
Molecular cloning of a gene involved in glucose sensing in the yeast Saccharomyces cerevisiae 250
Role of guanine nucleotides in the regulation of the Ras/cAMP pathway in Saccharomyces cerevisiae 246
Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator 243
Anti-aging effects of plant extracts on eukaryotic models of Parkinson’s disease 239
Mutations of the CK2 phosphorylation site of Sic1 affect cell size and S-Cdk kinase activity in Saccharomyces cerevisiae 238
Snf1/AMPK fine-tunes TORC1 signaling in response to glucose starvation 235
Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review 232
The CK2 phosphorylation of catalytic domain of Cdc34 modulates its activity at the G1 to S transition in Saccharomyces cerevisiae 223
Serine metabolism during differentiation of human iPSC-derived astrocytes 220
A surface-activated chemical ionization approach allows quantitative phosphorylation analysis of the cyclin-dependent kinase inhibitor Sic1 phosphorylated on Ser201 210
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 200
The number of SCB elements in the promoters of G1-regulon genes affects their expression during the G1/S phase transition 200
Exploring carbon source related localization and phosphorylation in the Snf1/Mig1 network using population and single cell-based approaches 196
Neuroprotective effects of verbascoside on eukaryotic models of Parkinson’s disease 188
NF-κB-mediated cytokine secretion and glutamate metabolic reprogramming converge in breast cancer brain tropism 187
Recent developments in the production and utilization of photosynthetic microorganisms for food applications 184
Glabranin as a natural modulator of AMPK signaling and lipid metabolism in non-alcoholic fatty liver disease 179
Characterization of Cacoa extract in eukaryotic models of Parkinson’s disease 178
Neuroprotective and anti-aging effects of plant extracts on eukaryotic models of Parkinson’s disease 174
Neuroprotective effects of plant extracts on eukaryotic models of Parkinson’s disease 170
Targeting NAFLD via AMPK activation and Lipid droplet clearance: The Role of natural bioactive compounds 164
Neuroprotective and anti-aging effects of cocoa-shell extract on eukaryotic models of Parkinson’s disease 159
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 153
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 139
Characterization of plant bioactive molecules in eukaryotic models of Parkinson’s disease 136
Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach 127
Identification of new sustainable biomolecules with neuroprotective effects: a multifaceted screening of the Mediterranean biodiversity 72
SNF1/AMPK controls its own localization by phosphorylating its activating kinase Sak1 21
Totale 23.009
Categoria #
all - tutte 66.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.135 78 121 144 114 65 123 96 53 50 53 93 145
2022/20231.806 231 523 179 153 155 213 23 104 110 23 59 33
2023/20241.364 40 37 33 127 136 344 218 90 101 18 46 174
2024/20253.596 214 193 366 179 261 196 143 164 268 489 562 561
2025/20269.012 893 405 738 909 997 823 1.312 346 732 719 504 634
2026/202777 77 0 0 0 0 0 0 0 0 0 0 0
Totale 23.009